Patents by Inventor Joyce Faber

Joyce Faber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10449248
    Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter; (b) at least 12 wt % of leucine, based on total proteinaceous matter; (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid; (d) an immune modulator; for improving the immune function in a mammal, preferably a human.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: October 22, 2019
    Assignee: N. V. Nutricia
    Inventors: Joyce Faber, Adrianus Lambertus Bertholdus Van Helvoort, Klaske Van Norren, Arjan Paul Vos, Robert Johan Joseph Hageman, Cornelus Johannes Petrus Van Limpt
  • Patent number: 9950013
    Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: April 24, 2018
    Assignee: N. V. Nutricia
    Inventors: Klaske Van Norren, Adrianus Lambertus Bertholdus Van Helvoort, Joyce Faber, Robert Johan Joseph Hageman, Arjan Paul Vos
  • Patent number: 9867796
    Abstract: The present invention relates to a combination of a leucine source and at least one unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia. The invention further relates to a combination of a leucine source and at least one unsaturated fatty acid source for reducing or avoiding a reduction in bone mineral density in a subject or for in vivo regulating of the blood plasma calcium homeostasis.
    Type: Grant
    Filed: July 25, 2014
    Date of Patent: January 16, 2018
    Assignee: N.V. Nutricia
    Inventors: Klaske Van Norren, Joyce Faber, Adrianus Lambertus Bertholdus Van Helvoort, Robert Johan Joseph Hageman
  • Publication number: 20170157177
    Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.
    Type: Application
    Filed: December 21, 2016
    Publication date: June 8, 2017
    Inventors: Klaske Van Norren, Adrianus Lambertus Bertholdus Van Helvoort, Joyce Faber, Robert Johan Joseph Hageman, Arjan Paul Vos
  • Patent number: 9642390
    Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: May 9, 2017
    Assignee: N.V. Nutricia
    Inventors: Klaske van Norren, Adrianus Lambertus Bertholdus van Helvoort, Joyce Faber, Robert Johan Joseph Hageman, Arjan Paul Vos
  • Publication number: 20150018277
    Abstract: The present invention relates to a combination of a leucine source and at least one unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia. The invention further relates to a combination of a leucine source and at least one unsaturated fatty acid source for reducing or avoiding a reduction in bone mineral density in a subject or for in vivo regulating of the blood plasma calcium homeostasis.
    Type: Application
    Filed: July 25, 2014
    Publication date: January 15, 2015
    Inventors: Klaske VAN NORREN, Joyce FABER, Adrianus Lambertus Bertholdus VAN HELVOORT, Robert Johan Joseph HAGEMAN
  • Publication number: 20150004130
    Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter; (b) at least 12 wt % of leucine, based on total proteinaceous matter; (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid; (d) an immune modulator; for improving the immune function in a mammal, preferably a human.
    Type: Application
    Filed: September 15, 2014
    Publication date: January 1, 2015
    Inventors: Joyce FABER, Adrianus Lambertus Bertholdus VAN HELVOORT, Klaske VAN NORREN, Arjan Paul VOS, Robert Johan Joseph HAGEMAN, Cornelus Johannes Petrus VAN LIMPT
  • Publication number: 20120122785
    Abstract: The present invention relates to a combination of a leucine source and at least one unsaturated fatty acid source for prophylactic or therapeutic treatment of hypercalcaemia. The invention further relates to a combination of a leucine source and at least one unsaturated fatty acid source for reducing or avoiding a reduction in bone mineral density in a subject or for in vivo regulating of the blood plasma calcium homeostasis.
    Type: Application
    Filed: May 27, 2010
    Publication date: May 17, 2012
    Applicant: N.V. NUTRICIA
    Inventors: Klaske van Norren, Joyce Faber, Adrianus Lambertus Bertholdus van Helvoort, Robert Johan Joseph Hageman
  • Publication number: 20110150824
    Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter; (b) at least 12 wt % of leucine, based on total proteinaceous matter; (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid; (d) an immune modulator; for improving the immune function in a mammal, preferably a human.
    Type: Application
    Filed: December 23, 2010
    Publication date: June 23, 2011
    Applicant: N.V. Nutricia
    Inventors: Joyce Faber, Adrianus Lambertus Bertholdus van Helvoort, Klaske van Norren, Arjan Paul Vos, Robert Johan Joseph Hageman, Cornelus Johannes Petrus van Limpt
  • Publication number: 20110152184
    Abstract: The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.
    Type: Application
    Filed: December 29, 2010
    Publication date: June 23, 2011
    Applicant: N.V. Nutricia
    Inventors: Klaske van Norren, Adrianus Lambertus Bertholdus van Helvoort, Joyce Faber, Robert Johan Joseph Hageman, Arjan Paul Vos